fda compounding semaglutide news october 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Novo Nordisk Calls for FDA

Refrigerate immediately after mixing

Elevated serum ferritin level as a predictor of reduced survival in patients with sporadic amyotrophic lateral sclerosis in China: a retrospective study

It also contains prebiotics, adaptogens like ashwagandha, and herbs to support digestion, immunity, and heart health

A meta-analysis of trials on injectable fat reduction found real average improvements but also a wide spread between individuals, which is why session counts vary

Naming the blood glucose-lowering substance 'pancreine'

In the field of hematology, vitamin B12 is recognized as an indispensable nutrient for the synthesis of healthy red blood cells